Shin Poong Pharm.Co.,Ltd. (019170.KS)
KRW 10370.0
(-5.04%)
KRW 10370.0
(-5.04%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -1119.00 KRW | -62.35% |
| 2022 | -688.79 KRW | -206.35% |
| 2021 | -224.84 KRW | -326.2% |
| 2020 | 99.40 KRW | -6.69% |
| 2019 | 106.53 KRW | 90.23% |
| 2018 | 56.00 KRW | 124.0% |
| 2017 | 25.00 KRW | 106.38% |
| 2016 | -392.02 KRW | -1220.06% |
| 2015 | 35.00 KRW | -64.65% |
| 2014 | 99.00 KRW | -25.93% |
| 2013 | 133.65 KRW | -62.16% |
| 2012 | 353.18 KRW | -42.25% |
| 2011 | 611.62 KRW | 15.28% |
| 2010 | 530.57 KRW | 6.34% |
| 2009 | 498.93 KRW | 74.92% |
| 2008 | 285.23 KRW | 36.39% |
| 2007 | 209.13 KRW | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -1.03 KRW | 97.97% |
| 2024 Q1 | -50.67 KRW | 92.19% |
| 2023 Q1 | -136.85 KRW | 58.73% |
| 2023 Q2 | -175.53 KRW | -28.26% |
| 2023 Q4 | -648.44 KRW | -312.84% |
| 2023 Q3 | -157.07 KRW | 10.52% |
| 2023 FY | - KRW | -62.35% |
| 2022 Q2 | -92.93 KRW | 13.65% |
| 2022 Q4 | -331.56 KRW | -75.63% |
| 2022 FY | - KRW | -206.35% |
| 2022 Q3 | -188.78 KRW | -103.14% |
| 2022 Q1 | -107.62 KRW | 52.43% |
| 2021 Q1 | 28.00 KRW | 180.56% |
| 2021 Q2 | 8.00 KRW | -71.43% |
| 2021 Q3 | -39.00 KRW | -587.5% |
| 2021 Q4 | -226.25 KRW | -480.13% |
| 2021 FY | - KRW | -326.2% |
| 2020 Q4 | 9.98 KRW | -47.47% |
| 2020 Q1 | 34.00 KRW | 45.49% |
| 2020 FY | - KRW | -6.69% |
| 2020 Q3 | 19.00 KRW | -47.22% |
| 2020 Q2 | 36.00 KRW | 5.88% |
| 2019 Q3 | 17.00 KRW | -65.31% |
| 2019 Q2 | 49.00 KRW | 172.22% |
| 2019 Q1 | 18.00 KRW | 223.8% |
| 2019 Q4 | 23.37 KRW | 37.47% |
| 2019 FY | - KRW | 90.23% |
| 2018 Q4 | -14.54 KRW | -185.53% |
| 2018 FY | - KRW | 124.0% |
| 2018 Q3 | 17.00 KRW | -52.78% |
| 2018 Q2 | 36.00 KRW | 100.0% |
| 2018 Q1 | 18.00 KRW | 112.8% |
| 2017 Q2 | 69.00 KRW | 165.38% |
| 2017 Q1 | 26.00 KRW | 106.0% |
| 2017 FY | - KRW | 106.38% |
| 2017 Q4 | -140.62 KRW | -342.45% |
| 2017 Q3 | 58.00 KRW | -15.94% |
| 2016 Q3 | -7.00 KRW | -114.0% |
| 2016 Q4 | -433.16 KRW | -6088.0% |
| 2016 Q1 | 4.00 KRW | -95.32% |
| 2016 FY | - KRW | -1220.06% |
| 2016 Q2 | 50.00 KRW | 1150.0% |
| 2015 FY | - KRW | -64.65% |
| 2015 Q1 | -0.29 KRW | 99.39% |
| 2015 Q4 | 85.46 KRW | 8446.0% |
| 2015 Q3 | 1.00 KRW | 102.08% |
| 2015 Q2 | -48.00 KRW | -16451.72% |
| 2014 Q4 | -47.89 KRW | -140.49% |
| 2014 Q1 | -94.23 KRW | -201.12% |
| 2014 FY | - KRW | -25.93% |
| 2014 Q2 | 95.19 KRW | 201.02% |
| 2014 Q3 | 118.27 KRW | 24.25% |
| 2013 Q2 | -178.44 KRW | -204.89% |
| 2013 Q3 | 53.62 KRW | 130.05% |
| 2013 Q4 | 93.19 KRW | 73.8% |
| 2013 FY | - KRW | -62.16% |
| 2013 Q1 | 170.12 KRW | 1030.63% |
| 2012 Q4 | -18.28 KRW | -119.04% |
| 2012 FY | - KRW | -42.25% |
| 2012 Q1 | 85.34 KRW | -57.16% |
| 2012 Q2 | 60.45 KRW | -29.17% |
| 2012 Q3 | 96.01 KRW | 58.83% |
| 2011 Q2 | 165.83 KRW | -19.3% |
| 2011 Q3 | 54.71 KRW | -67.01% |
| 2011 Q4 | 199.20 KRW | 264.1% |
| 2011 FY | - KRW | 15.28% |
| 2011 Q1 | 205.49 KRW | 214.98% |
| 2010 Q1 | 173.61 KRW | 34.79% |
| 2010 FY | - KRW | 6.34% |
| 2010 Q3 | 106.72 KRW | -42.8% |
| 2010 Q4 | 65.24 KRW | -38.87% |
| 2010 Q2 | 186.56 KRW | 7.46% |
| 2009 Q1 | 61.16 KRW | -9.35% |
| 2009 Q2 | 138.18 KRW | 125.93% |
| 2009 Q3 | 169.96 KRW | 23.0% |
| 2009 Q4 | 128.80 KRW | -24.22% |
| 2009 FY | - KRW | 74.92% |
| 2008 Q3 | 46.56 KRW | -53.29% |
| 2008 Q1 | 74.61 KRW | 180.49% |
| 2008 FY | - KRW | 36.39% |
| 2008 Q4 | 67.47 KRW | 44.91% |
| 2008 Q2 | 99.67 KRW | 33.59% |
| 2007 Q3 | 35.30 KRW | -59.76% |
| 2007 Q2 | 87.72 KRW | 63.99% |
| 2007 Q1 | 53.49 KRW | 0.0% |
| 2007 FY | - KRW | 0.0% |
| 2007 Q4 | 26.60 KRW | -24.65% |